AlphaFold predicted structure
UBR1 · Q8IWV7

Mean pLDDT
84.7/ 100
Confident
1,749 residues
Confidence breakdown
- Very high(≥ 90)51%
- Confident(70–90)37%
- Low(50–70)7%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ubiquitin protein ligase E3 component n-recognin 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalJohanson-Blizzard syndrome
hereditary disease
neurodegenerative disease
aortic stenosis
Intellectual disability
microcephaly
autism spectrum disorder
gastric cancer
hereditary continuous muscle fiber activity
Emery-Dreifuss muscular dystrophy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
E3 ubiquitin-protein ligase UBR1
E3 ubiquitin-protein ligase which is a component of the N-end rule pathway (PubMed:15548684, PubMed:16311597, PubMed:18162545, PubMed:20835242, PubMed:28392261). Recognizes and binds proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation (PubMed:18162545, PubMed:20835242, PubMed:28392261). Recognizes both type-1 and type-2 N-degrons, containing positively charged amino acids (Arg, Lys and His) and bulky and hydrophobic amino acids, respectively (PubMed:18162545). Does not ubiquitinate proteins that are acetylated at the N-terminus (PubMed:20835242). In contrast, it strongly binds methylated N-degrons (PubMed:28392261). Binds leucine and is a negative regulator of the leucine-mTOR signaling pathway, thereby controlling cell growth (PubMed:20298436)
UBR1 · Q8IWV7

Mean pLDDT
84.7/ 100
Confident
1,749 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0